Investigation of the cerebral energy status in patients with glutaric aciduria type I by 31P magnetic resonance spectroscopy

Neuropediatrics

Volumn 34, Issue 2, 2003, Pages 57-60

  Moller H E ^a,b,d   Koch, H G ^b   Weglage, J ^b   Freudenberg, F ^c   Ullrich, K ^c  

^a M P Inst Neuropsychol Forsch   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

Energy metabolism; Glutaric aciduria type I; Glutaryl CoA dehydrogenase deficiency; Magnetic resonance spectroscopy

Indexed keywords

CREATINE; CREATINE PHOSPHATE; GLUTARIC ACID; GLUTARYL COENZYME A DEHYDROGENASE;

ADULT; AMINOACIDURIA; ARTICLE; BRAIN METABOLISM; CASE REPORT; CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; ENERGY METABOLISM; ENZYME DEFICIENCY; GLUTARIC ACIDURIA 1; GLUTARYL COENZYME A DEHYDROGENASE DEFICIENCY; HUMAN; MALE; MITOCHONDRIAL RESPIRATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADENOSINE TRIPHOSPHATE; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; ENERGY METABOLISM; GLUTARYL-COA DEHYDROGENASE; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLISM, INBORN ERRORS; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHOSPHATES; PHOSPHOCREATINE; PILOT PROJECTS; TELENCEPHALON;

EID: 0038249129     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39596     Document Type: Article

References (20)

1. Amir N, el-Peleg O, Shalev RS, Christensen E. Glutaric aciduria type I: Clinical heterogeneity and neuroradiologic features. Neurology 1987; 37: 1654-1657
2. Bjugstad KB, Goodman SI, Freed CR. Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J Pediatr 2000; 137: 681-686
3. Brismar J, Ozand PT. CT and MR of the brain in glutaric acidemia type I: A review of 59 published cases and a report of 5 new patients. AJNR Am J Neuroradiol 1995; 16: 675-683
4. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982; 79: 3523-3526
5. 31p MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter. Magn Reson Med 1994; 32: 447-452
6. Das AM, Lücke T, Ullrich K. Glutaric aciduria I. Creatine supplementation restores creatine phosphate in mixed cortex cells incubated with 3-hydroxyglutarate. J Inher Metab Dis 2000; 23 (Suppl 1): 100
7. Flott-Rahmel B, Falter C, Schluff P, Fingerhut R, Christensen E, Jakobs C et al. Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidemia I. J Inher Metab Dis 1997; 20: 387-390
8. Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG. Glutaric aciduria: Biochemical and morphologic considerations. J Pediatr 1977; 90: 746-750
9. Gregersen N, Brandt NJ. Ketotic episodes in glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Pediatr Res 1979; 13: 977-981
10. Hoffmann GF, Gibson KM, Trefz FK, Nyhan WL, Bremer HJ, Rating D. Neurological manifestations of organic-acid disorders. Eur J Pediatr 1994; 153 (Suppl 1): S94-S100
11. Hoffmann GF, Athanassopoulos S, Burlina AB, Duran M, de Klerk JBC, Lehnert W et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 1996; 27: 115-123
12. Kölker S, Ahlemeyer B, Kriegelstein J, Hoffmann GF. 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inher Metab Dis 1999; 22: 259-262
13. Kölker S, Bachmann C, Hoffmann GF. Creatine attenuates excitotoxicity in an in vitro model of glutaric aciduria type 1: Impact for therapy? J Inher Metab Dis 2000; 23 (Suppl 1): 101
14. Land JM, Goulder P, Johnson A, Hockaday J. Glutaric aciduria type-1 - an atypical presentation together with some observations upon treatment and the possible cause of cerebral damage. Neuropediatrics 1992; 23: 322-326
15. Leibel RL, Shih VE, Goodman SI, Bauman ML, McCabe ER, Zwerdling RG et al. Glutaric acidemia: A metabolic disorder causing progressive choreoatheosis. Neurology 1980; 30:1163-1168
16. 31p magnetic resonance spectroscopy. Eur J Pediatr 1995; 154 (Suppl 2): S8-S13
17. 31p NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy. NMR Biomed 1996; 9: 347-358
18. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations. J Neuropathol Exp Neurol 1987; 46: 419-430
19. Taylor DJ, Styles P, Matthews PM, Arnold DA, Gadian DG, Bore P et al. Energetics of human muscle: Exercise-induced ATP depletion. Magn Reson Med 1986; 3: 44-54
20. Ullrich K, Flott-Rahmel B, Schluff P, Musshoff U, Das A, Lücke T. Glutaric aciduria type I: Pathomechanisms of neurodegeneration. J Inher Metab Dis 1999; 22: 392-403